Hims & Hers Health Inc. (HIMS) Next Earnings Date & Options-Implied ±7.1% Move
Hims & Hers Health Inc. (HIMS) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (66/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (-17.6% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Options-Implied Post-Earnings ±7.1% Bell Curve
Will HIMS Beat & Rip or Miss Next Quarter?
Trailing EPS: $0.55 • YoY Revenue Growth: 59%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.35B | $128.4M | $194.4M | 73.8% |
| FY 2024 | 2024-12-31 | $1.48B | $126.0M | $184.6M | 79.5% |
| FY 2023 | 2023-12-31 | $872.0M | -$23.5M | $34.2M | 44% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring HIMS)
- ✓Live walkthrough of HIMS's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
HIMS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +59.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HIMS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HIMS. Explore sector supply chains on /butterfly.
HIMS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is HIMS's next earnings date?
Based on SEC filing cadence, Hims & Hers Health Inc. (HIMS)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is HIMS stock expected to move on earnings?
Options markets currently imply a ±7.1% post-earnings move for HIMS, projecting a trading range between $27.56 and $31.78.